Skip to content

The effects of kinesiology taping, submucosal dexamethasone and serratiopeptidase on post-operative inflammatory sequelae after mandibular third molar surgery- a randomized study

The effects of kinesiology taping, submucosal dexamethasone and serratiopeptidase on post-operative inflammatory sequelae after mandibular third molar surgery- a randomized study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202205478844180
Enrollment
87
Registered
2022-05-18
Start date
2022-05-16
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Health

Interventions

Kinesiology Taping
Submucosal dexamethasone
Not used

Sponsors

Adeyemi Adewale Charles
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Consenting patients whose ages shall be between 18 to 40 years and shall be willing to return for follow-up visits. 2. Patients with impaction of mandibular third molars that belong to Pell and Gregory Class IIA and B diagnosed using preoperative periapical radiographs. 3. Patients with no history of allergies to dexamethasone and serratiopeptidase. 4. Patients that are free of clinical evidence of infection and without pericoronal inflammation around mandibular third molars. 5. American society of Anaesthesiologist I (ASA I) health status.

Exclusion criteria

Exclusion criteria: 1. Patients who do not consent after being fully informed about the study. 2. Patients with chronic systemic diseases such as diabetes mellitus, hepatic or renal diseases. 3. Pregnant or lactating patients. 4. Patients with bleeding disorders or who are on anticoagulant therapy. 5. Patients with acute viral, fungal or bacterial infections. 6. Patients with missing upper or lower central incisors. 7. Patients with long-term use of medications that would obscure assessment of the inflammatory response such as patients on immunosuppressants. 8. Mentally unstable patients with past or present history of psychiatric illness.

Design outcomes

Primary

MeasureTime frame
Pain

Secondary

MeasureTime frame
Facial swelling;Trismus

Countries

Nigeria

Contacts

Public ContactBabatunde Aregbesola

Consultant

tttaregs@yahoo.com+2348067033931

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026